OpenVSafe by OpenVAERS
Search V-safe

VMH-26431-43946

3 vaccinations 12 coded responses 31 check-ins 6 free-text entries 2 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
200 / DC
Registered
2022-06-23
Relationship
Child or adolescent in my care
Guardian
3SK-69264-16710
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2022-06-23
    Registered in v-safe
  2. 2022-06-23
    Dose 1 — Moderna
  3. 2022-06-23
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-06-24
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Psychomotor hyperactivity — Feeling: Fair · Irritability/crying
    Free text: Some hyperactivity. (Could be due to feeling tired.)
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-06-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-06-30
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-07-07
    Survey response — day 14, dose 1, under 3
    MedDRA: Vomiting — Feeling: Fair
    Free text: Vomiting
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-07-14
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-07-21
    Dose 2 — Moderna
  12. 2022-07-21
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · Site: Pain · None
    Under 3 check-in
  13. 2022-07-22
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Swelling/hardness · None
    Under 3 check-in
  14. 2022-07-23
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Swelling/hardness · Fever · Sleepiness
    Under 3 check-in
  15. 2022-07-24
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Swelling/hardness · None
    Under 3 check-in
  16. 2022-07-25
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Swelling/hardness · None
    Under 3 check-in
  17. 2022-07-28
    Survey response — day 7, dose 2, under 3
    MedDRA: Gastrooesophageal reflux disease — Feeling: Good · Irritability/crying
    Free text: Reflux
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-08-04
    Survey response — day 14, dose 2, under 3
    MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Good
    Free text: Congestion, runny nose
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-08-11
    Survey response — day 21, dose 2, under 3
    MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, congestion.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-08-18
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-08-27
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-09-04
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-10-24
    Survey response — 3 months, dose 2, under 3
    MedDRA: Gastroenteritis viral, Rhinorrhoea — Feeling: Good
    Free text: Various sniffles, tummy bugs and other normal toddler things.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2023-01-24
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  25. 2023-02-28
    Dose 3 — Moderna
  26. 2023-02-28
    Health check-in — day 0, dose 3, under 3
    Feeling: Good · None
    Under 3 check-in
  27. 2023-03-01
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Good · Site: Pain · None
    Under 3 check-in
  28. 2023-03-03
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Restlessness — Feeling: Good · Site: Pain
    MedDRA releases: 2024-11
  29. 2023-03-04
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Nasopharyngitis — Feeling: Good
    MedDRA releases: 2024-11
  30. 2023-03-05
    Survey response — days 1–6 daily, dose 3, under 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Fair
    MedDRA releases: 2024-11
  31. 2023-03-09
    Survey response — day 7, dose 3, under 3
    MedDRA: Middle insomnia, Rhinorrhoea — Feeling: Good
    MedDRA releases: 2024-11
  32. 2023-03-30
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  33. 2023-04-05
    Health check-in — day 35, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  34. 2023-04-11
    Survey response — day 42, dose 3, under 3
    MedDRA: Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  35. 2023-04-11
    Report sent to call center — day 42, dose 3, under 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  36. 2023-04-12
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  37. 2023-06-01
    Survey response — 3 months, dose 3, under 3
    MedDRA: Nasopharyngitis, Viral infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  38. 2023-06-01
  39. 2023-06-02

Vaccinations

DoseDateManufacturerCo-administered
12022-06-23Moderna No
22022-07-21Moderna No
32023-02-28Moderna No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-06-24

Systemic reaction (other): Some hyperactivity. (Could be due to feeling tired.)

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-07

Symptoms: Vomiting

Release 12 (Under 3) — day 7, dose 2, under 3

2022-07-28

Systemic reaction (other): Reflux

Release 12 (Under 3) — day 14, dose 2, under 3

2022-08-04

Symptoms: Congestion, runny nose

Release 12 (Under 3) — day 21, dose 2, under 3

2022-08-11

Symptoms: Runny nose, congestion.

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-24

Symptoms: Various sniffles, tummy bugs and other normal toddler things.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGastroenteritis viral · · ✓
SDNasopharyngitis · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓
SDViral infection · · ✓
SDVomiting · · ✓
SROCough · · ✓
SROGastrooesophageal reflux disease · · ✓
SROMiddle insomnia · · ✓
SRONasopharyngitis · · ✓
SROPsychomotor hyperactivity · · ✓
SRORestlessness · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release